Syntheses of polyrotaxane conjugated with 5-fluorouracil and vitamins with improved antitumor activities

Abstract

New antitumor active polyrotaxanes, presynthesized from β-cyclodextrin and polypropylene glycol, were first end capped with antitumor active drug, 5-fluorouracil, and further conjugated with 5-fluorouracil and various bioactive vitamin derivatives such as succinyl vitamin B₂ (PRTVB₂) and ascorbic acid 6-palmitate (PRTASP). FT-IR, ¹H, and ¹³C-NMR spectroscopies and elemental analysis were used to characterize the synthesized polyrotaxane and degree of 5-fluorouracil/vitamins substitution to β-cyclodextrin. The in vitro cytotoxicities of polyrotaxane conjugates were evaluated with mouse mammary carcinoma (FM3A), mouse leukemia (P388), human histiocytic lymphoma (U937) as cancer cell lines, and mouse liver cells (AC2F) as a normal cell line. The cytotoxicities of the polyrotaxane–ascorbic acid conjugates against AC2F normal cell line decreased more than 18,000% as compared with those of 5-fluorouracil. The in vivo antitumor activities of synthesized 5-fluorouracil-1-acetic acid-polyrotaxane (5-FUA-PRT) against mice bearing sarcoma 180 tumor cell line were greater than of 5-fluorouracil at concentration of 800 mg/kg.

Keywords

Polyrotaxane 5-flourouracil in vitro cytotoxicity antitumor activity ascorbic acid

Get full access to this article

View all access options for this article.

References

Watanabe

Ooya

Nitta

et al . Fibroblast adhesion and proliferation on poly(ethylene glycol) hydrogels crosslinked by hydrolyzable polyrotaxane. Biomaterials 2002; 23: 4041–4048.

Chung

Lee

et al . Syntheses of cyclodextrin-3′-azido-3′-deoxythymidine conjugates and their sulfates with improved. J Polym Sci A1 2006; 44: 295–303.

Jung

Yerri Swamy

Moon

et al . Anti-AIDS active polyrotaxane-AZT conjugates with bioactive bulky stoppers and their nanoparticles. J Polym Sci A1 2012; 50: 4895–4901.

Moon

Kwon

Lee

et al . In vitro assessment of a novel polyrotaxane-based drug delivery system integrated with a cell-penetrating peptide. J Control Release 2007; 124: 43–50.

Pinedo

Peters

GF.

Fluorouracil: biochemistry and pharmacology. J Clin Oncol 1988; 6: 1653–1664.

Lee

Swamy

Lee

et al . Antitumor and antiangiogenic active dendrimer/5-fluorouracil conjugates. J Biomed Mater Res A 2013; 101A: 2306–2312.

Nichifor

Schacht

Seymour

et al . Cytotoxicity and anticancer activity of macromolecular prodrugs of 5-fluorouracil. J Bioact Compat Pol 1997; 12: 265–281.

Umrigar

Ohashi

Butler

GB.

Synthesis and properties of alternating copolymers of potential antitumor activity containing 5-fluorouracil. J Polym Sci A1 1979; 17: 351–363.

Chung

Jung

Lee

et al . Syntheses, antitumor activities, and antiangiogenesis of exo-3,6-epoxy-1,2,3,6-tetrahydrophthalimidoethanoyl-5-fluorouracil and its polymers. J Polym Sci A1 2000; 38: 4272–4281.

10.

Lee

Kim

et al . Syntheses and evaluations of antitumor and antiangiogenic compounds conjugated with 5-fluorouracil and ascorbic acid. J Bioact Compat Pol 2008; 23: 473–489.

11.

Wenz

Kräuter

Sackmann

Assembly of a fluorescent cyclodextrin polyrotaxane and its detection by fluorescence microscopy. J Polym Sci A1 2009; 47: 6223–6230.

12.

Mocanu

Vizitiu

Carpov

Cyclodextrin polymers. J Bioact Compat Pol 2001; 16: 315–342.

13.

Matsumura

Maeda

A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 1986; 46: 6387–6392.

14.

Ooya

Yui

Synthesis of theophylline-polyrotaxane conjugates and their drug release via supramolecular dissociation. J Control Release 1999; 58: 251–269.

15.

Udo

Hokonohara

Motoyama

et al . 5-Fluorouracil acetic acid/beta-cyclodextrin conjugates: drug release behavior in enzymatic and rat cecal media. Int J Pharm 2010; 388: 95–100.

16.

Ooya

Yui

Polyrotaxanes: synthesis, structure, and potential in drug delivery. Crit Rev Ther Drug 1999; 16: 289–330.

17.

Ooya

Mori

Terano

et al . Synthesis of a biodegradable polymeric supramolecular assembly for drug delivery. Macromol Rapid Comm 1995; 16: 259–263.

18.

Yui

Ooya

Kumeno

Effect of biodegradable polyrotaxanes. Bioconjugate Chem 1998; 9: 9118–9125.

19.

Tian

et al . A novel pH-sensitive (±)-α-tocopherol-5-fluorouracil adduct with antioxidant and anticancer properties. Chem Commun 2011; 47: 10713–10715.

20.

Mosmann

Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J Immunol Methods 1983; 65: 55–63.

21.

Gam

Jeong

Lee

Cho

Synthesis and biological activities of copolymers of N-Glycinyl maleimide with methacrylic acid and vinyl acetate. J Appl Polym Sci 1995; 57: 219-225.

22.

Jung

Chung

Lee

Park

Cho

Syntheses, antitumor activities and anti-angiogenesis of a monomer and its medium molecular weight polymers: maleimidoethanoyl-5-flurouracil and its polymers. J Polym Sci Part A: Polym Chem 2000; 38:1247-1256.

23.

Oikawa

Hirotani

Nakamura

et al . A highly potent antiangiogenic activity of retinoids. Cancer Lett 1989; 48: 157–162.

24.

Crum

Szabo

Folkman

A new class of steroids inhibits angiogenesis in the presence of heparin or a heparin fragment. Science 1985; 230: 1375–1378.

25.

Yokoyama

Kwon

Okano

et al . Preparation of micelle-forming polymer-drug conjugates. Bioconjugate Chem 1992; 3: 295–301.

26.

Zhu

Liu

et al . Biamphiphilic triblock copolymer micelles as a multifunctional platform for anticancer drug delivery. J Biomed Mater Res A 2011; 96A: 330–340.